Over 130 novel vaccine delivery devices, including marketed / under development products(RootsAnalys
Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration. Currently, many biopharmaceutical companies and clinical research institutes are engaged in the development of novel vaccine delivery systems, taking into consideration the specific requirements of large scale immunization initiatives. As a result, significant efforts have been put into the development of drug delivery technologies / devices, such as microneedle patches, electroporation-based needle free injection systems, jet injectors, inhalation-based delivery systems, biodegradable implants and certain novel types of oral delivery systems. It is worth highlighting that most of the aforementioned systems are specifically being designed to facilitate pain-free administration of vaccines and allow self-administration.
To order this 500+ page report, which features 90+ figures and 160+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html
The USD 1.5 billion (by 2030) financial opportunity within the novel vaccine delivery devices market has been analyzed across the following segments:
Type of device
Electroporation-based needle free injection system
Oral delivery systems
Nasal delivery systems
Jet injectors
Microneedle patches
Microinjectors
Route of administration
Oral
Intramuscular
Intranasal
Intradermal
Subcutaneous
Type of vaccine
Bivalent Oral Polio Vaccine
BCG Vaccine
DTP-HepB-Hib Vaccine
Pneumococcal Conjugate Vaccine
Influenza Vaccine
Measles Vaccine
Tetanus-Diphtheria Vaccine
Others
Key geographical regions
North America
Europe
Asia Pacific
Rest of the world
The Novel Vaccine Delivery Devices Market, 2019-2030 report features the following companies,
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com